


Our cultivation site is located in the Maseru district of Lesotho, at approximately 1,500 metres above sea level. It is one of the most naturally suited environments for cannabis cultivation anywhere in the world.
The site provides the volume base for our production model. Lesotho’s long growing season, intense solar resource and low humidity create conditions that reduce supplemental inputs dramatically versus controlled-environment facilities.
Our hybrid polytunnel delivers perpetual-harvest indoor production. High-density planting of single-cola plants on short vegetative cycles maximises canopy utilisation and produces uniform, pharmaceutical-grade flower year-round, eliminating seasonal supply gaps.
A larger greenhouse facility is planned to materially increase indoor capacity. Designed to be self-funding from operating cash flow, this phase transitions the site from proof-of-concept to commercial-scale production.


Everything you need to know about Frontier Botanics, our operations, and the investment opportunity.
Yes. Medical cannabis has been legal in the UK since November 2018 following changes introduced after high-profile cases like that of Alfie Dingley. However, access is tightly regulated and prescriptions are typically issued by specialist doctors. Frontier Botanics operates fully within UK and international legal frameworks to ensure compliance at every stage of production and distribution.
Lesotho was the first African nation to legalise medical cannabis cultivation and export, offering a stable regulatory environment, favourable climate, and cost-efficient production conditions. This allows Frontier Botanics to produce high-quality, pharmaceutical-grade cannabis at scale while maintaining competitive pricing for international markets.
Frontier Botanics focuses on vertically integrated operations—from cultivation in Lesotho to distribution in the UK—ensuring full control over quality, compliance, and supply chain efficiency. The company combines pharmaceutical standards with scalable infrastructure, positioning itself to meet growing demand in regulated global markets.
Frontier Botanics is currently raising capital to expand cultivation capacity, enhance processing facilities, and secure additional distribution partnerships. The funding round is designed to accelerate growth, increase production output, and strengthen the company’s position within the rapidly expanding global medical cannabis market.
The global medical cannabis market is projected to grow significantly over the coming decade, driven by increasing legalisation, patient demand, and clinical research. Countries across Europe—including the UK—are gradually expanding access, creating a strong long-term growth opportunity for early-stage, compliant operators like Frontier Botanics.
New Frontier Holdings Ltd
First Floor 690 Great West Road, Osterley Village, Isleworth, England TW7 4PU
Company No. 12111072
England & Wales
Frontier Botanics Lesotho (Proprietary) Limited, Morena Khoase Kolobe, Mohalalitoe Road Maseru, Kingdom of Lesotho
© 2026 New Frontier Holdings Ltd.